447 related articles for article (PubMed ID: 19606728)
21. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Solomon SD
Curr Opin Cardiol; 2006 Nov; 21(6):613-7. PubMed ID: 17053413
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Hermann M; Ruschitzka F
Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
[TBL] [Abstract][Full Text] [Related]
23. Risks and benefits of celecoxib to prevent recurrent adenomas.
Psaty BM; Potter JD
N Engl J Med; 2006 Aug; 355(9):950-2. PubMed ID: 16943408
[No Abstract] [Full Text] [Related]
24. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention.
Scarpignato C; Hunt RH
Gastroenterol Clin North Am; 2010 Sep; 39(3):433-64. PubMed ID: 20951911
[TBL] [Abstract][Full Text] [Related]
26. Update on nonsteriodal anti-inflammatory drugs.
Ardoin SP; Sundy JS
Curr Opin Rheumatol; 2006 May; 18(3):221-6. PubMed ID: 16582683
[TBL] [Abstract][Full Text] [Related]
27. Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas".
Cen YY
Circulation; 2007 Mar; 115(12):e348; author reply e349. PubMed ID: 17389275
[No Abstract] [Full Text] [Related]
28. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.
Fiorucci S
Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261
[TBL] [Abstract][Full Text] [Related]
29. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
Nurmohamed MT
Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165
[No Abstract] [Full Text] [Related]
30. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
Hennekens CH; Borzak S
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
[TBL] [Abstract][Full Text] [Related]
31. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Farkouh ME; Greenberg BP
Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Chan EP; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
[TBL] [Abstract][Full Text] [Related]
33. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
[TBL] [Abstract][Full Text] [Related]
34. [Analgesics, NSAIDS, and coxibs in rheumatic pain].
Di Matteo L
Reumatismo; 2006; 58 Spec No.1():84-9. PubMed ID: 23631071
[No Abstract] [Full Text] [Related]
35. Chemoprevention of colorectal cancer.
Raju R; Cruz-Correa M
Dis Colon Rectum; 2006 Jan; 49(1):113-24; discussion 124-5. PubMed ID: 16362805
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs.
Bus PJ; Verspaget HW; Lamers CB; Griffioen G
Scand J Gastroenterol Suppl; 2000; (232):101-4. PubMed ID: 11232485
[TBL] [Abstract][Full Text] [Related]
37. Chemoprevention of colorectal cancer: why all the confusion?
Bresalier RS
Curr Opin Gastroenterol; 2008 Jan; 24(1):48-50. PubMed ID: 18043232
[TBL] [Abstract][Full Text] [Related]
38. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
Rostom A; Moayyedi P; Hunt R;
Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
[TBL] [Abstract][Full Text] [Related]
39. Diabetes, colorectal cancer and cyclooxygenase 2 inhibition.
Smith CJ; McKay GA; Fisher M
Int J Clin Pract; 2008 May; 62(5):810-5. PubMed ID: 18373616
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Jones R; Rubin G; Berenbaum F; Scheiman J
Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
